STATEHOUSE (May 9, 2014) — The Indiana Health Industry Forum (IHIF) recently presented State Sen. Brandt Hershman (R-Buck Creek) its “Legislator of the Year” award. The honor recognizes Hershman’s efforts to expand access to pharmaceutical drugs substituted for biologically comparable name-brand products – alternatives known as “biosimilars.”
During the 2014 legislative session, Hershman authored a new law that allows pharmacists to dispense biosimilars in place of name-brand medications. To ensure the process’ safety and transparency, the law requires the biosimilar drug to be approved for replacement by the U.S. Food and Drug Administration and establishes a communication process between the patient, pharmacist and doctor.
“Biosimilars are becoming a bigger part of cutting-edge health-care technology, and Indiana is staying ahead of the curve by opening opportunities to use these advancements,” Hershman said. “With this new law, Hoosier patients will have more options for their prescription medications that are both effective and affordable. I anticipate other states will soon follow Indiana’s lead.”
Hershman and the legislation’s House sponsor, State Rep. Ed Clere (R-New Albany) were both recognized at IHIF’s annual meeting on Tuesday, May 6 in Indianapolis.
“We are pleased to have the opportunity to recognize the contribution Representative Clere and Senator Hershman have made to advancing patient safety and promoting innovation in Indiana,” IHIF President and CEO Kristin Jones said. “Indiana is now a national leader in providing access to these life-saving and life-changing therapies to patients in need.”
IHIF is Indiana’s trade association for companies in the medical device and health science sectors. For more information on the organization, click here.